Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The mouse lymphoma assay.

J Clements1

  • 1Covance Laboratories Limited, Otley Road, North Yorkshire, HG3 1PY, Harrogate, UK. julie.clements@covance.com

Mutation Research
|December 13, 2000
PubMed
Summary
This summary is machine-generated.

This paper reviews the Mouse Lymphoma Assay (MLA) protocol, discussing its history, current status, and areas for improvement. It covers both soft agar and microwell versions, highlighting variations and recent guidelines for genotoxicity testing.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prehabilitation in the prison population.

Anaesthesia reports·2024
Same author

Recent advancements and application of in vitro models for predicting inhalation toxicity in humans.

Toxicology in vitro : an international journal published in association with BIBRA·2021
Same author

Facing the Ethical Challenges: Consumer Involvement in COVID-19 Pandemic Research.

Journal of bioethical inquiry·2020
Same author

An experimental aerosol air-agar interface mouse lymphoma assay methodology.

Mutation research. Genetic toxicology and environmental mutagenesis·2020
Same author

First Reports of Brown Fruit Rot on Sweet Cherry (Prunus avium) and Plum (P. domestica) and Shoot Blight on Apricot (P. armeniaca), Kwanzan Cherry (P. serrulata), and Sweet Cherry (P. avium) Caused by Monilinia laxa in New York, Rhode Island, and Massachusetts.

Plant disease·2019
Same author

Bone marrow-derived stem/stromal cells (BMSC) 3D microtissues cultured in BMP-2 supplemented osteogenic induction medium are prone to adipogenesis.

Cell and tissue research·2018
Same journal

Monoallelic germline RAD51C, RAD51D, and BRIP1 variants in hereditary cancer testing: Variant spectrum and clinical counselling implications.

Mutation research·2026
Same journal

Prediction of hepatocellular carcinoma associated biomarkers in TP53 gene; A comprehensive in silico analysis.

Mutation research·2026
Same journal

IDH1 mutation promotes angiogenesis via upregulation of hypoxia inducible factor 1 alpha in glial tumors.

Mutation research·2026
Same journal

Targeting overexpressed oncogenes in esophageal cancer through miRNA-mediated gene silencing: Insights from binding affinity and thermodynamic profiling.

Mutation research·2026
Same journal

The active compound quercetin from Polygonum cuspidatum targets COL3A1 to enhance CD8⁺ T cell cytotoxicity in gastric cancer.

Mutation research·2026
Same journal

E2F1 promotes LIHC malignant phenotype via NEK2-mediated Wnt/β-catenin and Notch activation and EMT.

Mutation research·2026
See all related articles

Area of Science:

  • Genotoxicity testing
  • In vitro toxicology
  • Mammalian cell assays

Background:

  • The Mouse Lymphoma Assay (MLA) is a key genotoxicity test.
  • Standardization of the MLA protocol has evolved over time.
  • The International Workshop on Genotoxicity Test Procedures (IWGTP) has guided protocol development.

Purpose of the Study:

  • To discuss the current status of the Mouse Lymphoma Assay protocol.
  • To review recent guidelines and consensus issues from the IWGTP.
  • To highlight protocol variations and areas for future development.

Main Methods:

  • Review of historical development of the MLA protocol.
  • Discussion of recent guidelines and IWGTP recommendations.
  • Comparison of soft agar and microwell versions of the MLA.

Related Experiment Videos

Main Results:

  • Current protocol recommendations for the MLA are presented.
  • Key areas for protocol improvement include cytotoxicity, treatment duration, acceptability criteria, and statistical analysis.
  • Variations between laboratories and assay versions (microwell vs. agar) are identified.

Conclusions:

  • The MLA protocol requires ongoing refinement for optimal genotoxicity assessment.
  • Standardization efforts aim to improve the reliability and consistency of MLA results.
  • Further research is needed to address identified areas for development in the MLA.